According to the company seeking approval, the agency said there was insufficient data to authorize the use of a treatment for post-traumatic stress disorder that involves the use of the drug known as Ecstasy.
According to the company seeking approval, the agency said there was insufficient data to authorize the use of a treatment for post-traumatic stress disorder that involves the use of the drug known as Ecstasy.